Medical School and Graduation Year:

Karadeniz Technical University Faculty of Medicine, 2001

Specialization Training and Year:

Okmeydanı Training and Research Hospital, Internal Medicine, 2009

Çukurova University Faculty of Medicine, Department of Internal Medicine, Medical Oncology Branch (Fellowship), 2013

Professional Experience:

Istanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital (Medical Oncology Specialist), 2013-2016

Neolife Medical Center, 2016-2018

Istanbul Aydın University Faculty of Medicine, Florya WM Medical Park Hospital, Department of Internal Medicine, Medical Oncology, 2017-2023

Medical Interests:

Breast Cancer

Lung Cancer

Gynecologic Cancers

Brain Tumors

Gastrointestinal Cancers (Colon-Stomach-Pancreas)

Special Experience:

Immunotherapy

Targeted Molecular Therapies

Scientific Publications

Articles published in international refereed journals

1.Günaldi M, Helvaci A, Yildirim ND, Kiskaç M, Küçükkaya RD. Acute myocardial infarction in a patient with hemophilia A and factor V Leiden mutation. Cardiol J. 2009;16(5):458-61. (SCI & SSCI & Arts and Humanities)

2.Duman BB, Kara IO, Günaldi M, Erçolak V. Primary cutaneous small-cell carcinoma: a case report. Med Oncol. 2011 Dec;28 Suppl 1:S634-5. doi: 10.1007/s12032-010-9672-3. .(SCI & SSCI & Arts and Humanities)

3.Duman BB, Kara IO, Günaldi M, Ercolak V. Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature. Arch Gynecol Obstet. 2011 Jun;283(6):1363-8. doi: 10.1007/s00404-011-1845-6. (SCI & SSCI & Arts and Humanities)

4.Gunaldi M, Helvaci A, Demirel Yildirim N, Aydin D, Kara N. Multiple myeloma with serous membrane involvement and increased CA-125 and CA 15-3. J BUON. 2011 Oct-Dec;16(4):778. (SCI & SSCI & Arts and Humanities)

5.Günaldi M, Oguz Kara I, Duman BB, Gumurdulu D. Primary intrapulmonary thymoma associated with myasthenia gravis. Gen Thorac Cardiovasc Surg. 2012 Sep;60(9):610-3. doi: 10.1007/s11748-012-0064-9.(SCI & SSCI & Arts and Humanities)

6.Duman BB, Paydas S, Tetiker T, Gunaldı M, Afsar CU, Erçolak V, Haksöyler V, Dilli MŞ.Capecitabine-induced hypertriglyceridemia and hyperglycemia: two cases. Pharmacology. 2012;90(3-4):212-5. doi: 10.1159/000342382. (SCI & SSCI & Arts and Humanities)

7.Duman BB, Afşar ÇU, Günaldi M, Sahin B, Kara IO, Erkisi M, Erçolak V. Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients. Asian Pac J Cancer Prev. 2012;13(8):4119-23. (SCI & SSCI & Arts and Humanities)

8.Duman BB, Gunaldi M, Ercolak V, Afsar CU, Sahin B, Erkisi IM, Kara O, Paydas S, Gönlüsen G, Sertdemir Y. Retrospective analysis of 498 primary soft tissue sarcomas in a single Turkish centre. Asian Pac J Cancer Prev. 2012;13(8):4125-8. (SCI & SSCI & Arts and Humanities)

9.Gunaldi M, Kara IO, Duman BB, Ercolak V. Primary intracerebral myeloid sarcoma. Onkologie. 2012;35(11):694-7. doi: 10.1159/000343953. (SCI & SSCI & Arts and Humanities)

10.Günaldi M, Paydas S, Afsar CU, Doran F Coexistence of tuberous sclerosis complex and malignant melanoma. Singapore Med J. 2013 Nov;54(11):e233-5 (SCI & SSCI & Arts and Humanities)

11.Günaldı M, Paydaş S, Usul Afşar C, Bozkurt Duman B, Erçolak V, Haksöyler V. Carbamazepine and multiple myeloma: possible interaction. Turk J Haematol. 2013 Mar;30(1):83-4. doi: 10.4274/tjh.2012.0153(SCI & SSCI & Arts and Humanities)

12.Usul Afşar C, Paydaş S, Günaldı M, Bozkurt Duman B, Erçolak V, Zorludemir S, Açıkalın A. Sweet syndrome in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma: curious lymphocyte/neutrophil fluctuations. Turk J Haematol. 2013 Dec;30(4):413-5. doi: 10.4274/Tjh.2012.0055. (SCI & SSCI & Arts and Humanities)

13.Erçolak V, Kara O, Günaldı M, Usul Afşar C, Bozkurt Duman B, Açıkalın A, Ergin M, Erdoğan S Bilateral primary adrenal non-hodgkin lymphoma. Turk J Haematol. 2014 Jun;31(2):205-6. doi: 10.4274/tjh.2013.0195. Epub 2014 Jun 10. (SCI & SSCI & Arts and Humanities)

14.Gunaldi M, Kara IO, Duman BB, Afsar CU, Ergin M, Avci A. A new approach to the treatment of metastatic paraganglioma: sorafenib. Cancer Res Treat. 2014 Oct;46(4):411-4. (SCI & SSCI & Arts and Humanities)

15.Sözütek D, Yanık S, Akkoca AN, Sözütek A, Ozdemir ZT, Avşar CU, Günaldı M, Sahin B, Doron F. Diagnostic and prognostic roles of DOG1 and Ki-67, in GIST patients with localized or advanced/metastatic disease. Int J Clin Exp Med. 2014 Jul 15;7(7):1914-22. (SCI & SSCI & Arts and Humanities)

16.Ercolak V, Paydas S, Ergin M, Ates BT, Duman BB, Gunaldi M, Afsar CU.Abdominal actinomycosis with multiple myeloma: A case report.Oncol Lett. 2014 Oct;8(4):1876-1878. (SCI & SSCI & Arts and Humanities)

17.Paydaş S, Ozdoğu H, Günaldı M, Haksöyler V, Açıkalın A, Ergin M. Extramedullary myeloid tumor involving the pancreas: a case report and review of the literature. Turk J Haematol. 2014 Sep 5;31(3):295-300. (SCI & SSCI & Arts and Humanities)

18.Günaldı M, Erkisi M, Afşar CU, Erçolak V, Paydas S, Kara IO, Sahin B, Gulec UK, Secilmis A. Evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisms in Turkish breast cancer patients receiving tamoxifen treatment. Pharmacology. 2014;94(3-4):183-9. (SCI & SSCI & Arts and Humanities)

19.Afsar CU, Gunaldi M, Kum P, Sahin B, Erkisi M, Kara IO, Paydas S, Duman BB, Ercolak V, Karaca F, Uyeturk U, Guner SI. Pancreatic carcinoma, thrombosis and mean platelet volume: single center experience from the southeast region of Turkey. Asian Pac J Cancer Prev. 2014;15(21):9143-6. (SCI & SSCI & Arts and Humanities)

20.Gunaldi M, Duman BB, Afsar CU, Paydas S, Erkisi M, Kara IO, Sahin B. Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study. J Oncol Pharm Pract. 2016 Apr;22(2):242-7 (SCI & SSCI & Arts and Humanities)

21.Karaca F, Afsar CU, Gunaldi M, Erkurt E, Ercolak V, Sertdemir Y, Paydas S. Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers. Int J Clin Exp Med. 2015 Jan 15;8(1):876-82. (SCI & SSCI & Arts and Humanities)

22.Okuturlar Y, Gunaldi M, Tiken EE, Oztosun B, Inan YO, Ercan T, Tuna S, Kaya AO, Harmankaya O, Kumbasar A.Utility of peripheral blood parameters in predicting breast cancer risk. Asian Pac J Cancer Prev. 2015;16(6):2409-12.(SCI & SSCI & Arts and Humanities)

23.Gunaldi M, Afsar CU, Okuturlar Y, Gedikbasi A, Kocoglu H, Kural A, Akarsu C, Gunduz U, Tiken EE.Elevated serum levels of heat shock protein 70 are associated with breast cancer. Tohoku J Exp Med. 2015;236(2):97-102. doi: 10.1620/tjem.236.97.(SCI & SSCI & Arts and Humanities)

24.Ercolak V, Paydas S, Bagir E, Ergin M, Seydaoglu G, Celik H, Yavu B, Tanriverdi K, Gunaldi M, Afsar CU, Duman BB. PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma. Acta Haematol. 2015;134(4):199-207. (SCI & SSCI & Arts and Humanities)

25.Gunaldi M, Goksu S, Erdem D, Gunduz S, Okuturlar Y, Tiken E, Kahraman S, Inan YO, Genc TB, Yildirim M.Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multicenter study.Int J Clin Exp Med. 2015 Apr 15;8(4):5937-42. eCollection 2015.(SCI & SSCI & Arts and Humanities)

26.Günaldi M, Afsar CU, Duman BB, Kara IO, Tatli U, Sahin B Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws. Oncol Lett. 2015 Jul;10(1):439-442. (SCI & SSCI & Arts and Humanities)

27.Karabulut M, Gunaldi M, Alis H, Afsar CU, Karabulut S, Serilmez M, Akarsu C, Seyit H, Aykan NF Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma. Clin Transl Oncol. 2016 Feb;18(2):160-71(SCI & SSCI & Arts and Humanities)

28.Okuturlar Y, Gedikbasi A, Akalin N, Gunaldi M, Yilmaz D, Mert M, Harmankaya O, Soylu A, Karakaya P, Kumbasar A.Serum paraoxonase 1 activity in patients with iron deficiency anemia. Arch Med Sci. 2016 Aug 1;12(4):697-703. doi: 10.5114/aoms.2015.48730. Epub 2016 Jul 1.(SCI & SSCI & Arts and Humanities)

29.Okuturlar Y, Ozkalemkas F, Ener B, Serin SO, Kazak E, Ozcelik T, Ozkocaman V, Ozkan HA, Akalin H, Gunaldi M, Ali R. Serum galactomannan levels in the diagnosis of invasive aspergillosis. Korean J Intern Med. 2015 Nov;30(6):899-905. (SCI & SSCI & Arts and Humanities)

30.Ercolak V, Sahin B, Gunaldi M, Duman BB, Afsar CU. Efficacy of paclitaxel in the treatment of Kaposi sarcoma. Eur Rev Med Pharmacol Sci. 2015 Nov;19(21):4095-100. (SCI & SSCI & Arts and Humanities)

31.Usul Afsar C, Sahin B, Gunaldi M, Kılıc Bagir E, Gumurdulu D, Burgut R, Erkisi M, Kara IO, Paydas S, Karaca F, Ercolak V. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung. Int J Clin Exp Pathol. 2015 Sep 1;8(9):9760-71 (SCI & SSCI & Arts and Humanities)

32.Gunaldi M, Okuturlar Y, Gedikbasi A, Akarsu C, Karabulut M, Kural A. Diagnostic importance of S100A9 and S100A12 in breast cancer. Biomed Pharmacother. 2015 Dec;76:52-6. doi: 10.1016/j.biopha.2015.10.029. Epub 2015 Nov 10.(SCI & SSCI & Arts and Humanities)

33.Karabulut M, Alis H, Bas K, Karabulut S, Afsar CU, Oguz H, Gunaldi M, Akarsu C, Kones O, Aykan NF. Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer. Mol Clin Oncol. 2015 Nov;3(6):1255-1267. (SCI & SSCI & Arts and Humanities)

34.Gunaldi M, Kocoglu H, Okuturlar Y, Gedikbasi A, Karabulut M, Alis H, Hursitoglu M.Heat shock protein 70 is a useful marker for predicting colorectal cancer. J BUON. 2015 Nov-Dec;20(6):1464-70.(SCI & SSCI & Arts and Humanities)

35.Afsar CU, Gunaldı M, Okuturlar Y, Gedikbası A, Tiken EE, Kahraman S, Karaca F, Ercolak V, Karabulut M.Paraoxonase-1 and arylesterase activities in patients with colorectal cancer. Int J Clin Exp Med. 2015 Nov 15;8(11):21599-604. (SCI & SSCI & Arts and Humanities)

36.Ekmen N, Helvaci A, Gunaldi M, Sasani H, Yildirmak ST. Leptin as an important link between obesity and cardiovascular risk factors in men with acute myocardial infarction. Indian Heart J. 2016 Mar-Apr;68(2):132-7. doi: 10.1016/j.ihj.2015.07.032 (SCI & SSCI & Arts and Humanities)

37.Kocoglu H, Dogan H, Oguz B, Ocak Serin S, Okuturlar Y, Gunaldi M, Erismis B, Ozdemir B, Tural D, Hursitoglu M, Harmankaya O, Kumbasar A.Comparison of Survival Rates, Tumor Stages, and Localization in between Obese and Nonobese Patients with Gastric Cancer. Gastroenterol Res Pract. 2016;2016:9382750. doi: 10.1155/2016/9382750. Epub 2016 Jun 21.(SCI & SSCI & Arts and Humanities)

38.Gündüz UR, Gunaldi M, Isiksacan N, Gündüz S, Okuturlar Y, Kocoglu H. A new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study. Mol Clin Oncol. 2016 Aug;5(2):355-360. (SCI & SSCI & Arts and Humanities)

39.Tanriverdi O, Menekse S, Teker F, Oktay E, Nur Pilanc K, Gunaldi M, Kocar M, Kacan T, Bahceci A, Avci N, Akman T, Cokmert S, Yesil-Cinkir H, Teoman Yanmaz M. The mean platelet volume may predict the development of isolated bone metastases in patients with breast cancer: a retrospective study of the Young Researchers Committee of the Turkish Oncology Group (TOG). J BUON. 2016 Jul-Aug;21(4):840-850. (SCI & SSCI & Arts and Humanities)

40.Gunaldi M, Kose F, Serkan Demirci N, Gunduz S, Ozdemir N, Kocoglu H, Okuturlar Y, Murat Sedef A, Erdem D, Sezgin Goksu S, Umut Erdem G, Yildirim M. Adding taxane to platin-5-fluorouracil combination does not improve survival rate in patients ≥ 65 years of age with advanced gastric cancer: A retrospective-multicenter study. J BUON. 2018 Mar-Apr;23(2):416-421. (SCI & SSCI & Arts and Humanities)

41.Gunaldi M, Isiksacan N, Kocoglu H, Okuturlar Y, Gunaldi O,Topcu TO,Karabulut M. The value of serum survivin level in early diagnosis of cancer. Journal of Cancer Therapeutics and Research. J Cancer Res Ther. 2018 Apr-Jun;14(3):570-573. (SCI & SSCI & Arts and Humanities)

42.Topcu TO, Ozdemir F, Kavgaci H, Gunaldi M, Kocoglu H, Imamoglu GI, Mentese A, Yaman SO, Orem A, Aydin F.The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer. J Cancer Res Ther. 2018 Apr-Jun;14(3):608-613. (SCI & SSCI & Arts and Humanities)

43.Okuturlar Y, Gunaldi M, Kocoglu H, Hursitoglu M, Gedikbasi A, Acarer D, Harmankaya O, Kumbasar A. Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer. Journal of Cancer Therapeutics and Research. J Cancer Res Ther. 2018 Jun;14(Supplement):S362-S367 (SCI & SSCI & Arts and Humanities)

44.Şişman H, Özgen R, Baysal D, Sarıakçalı N, Öztürk S, Kum P, Gürel D, Kanarığ D, Aslaner E, Akıl Y, Günaldı M. Measurement of the knowledge level about breast self-exam among the female employees of a university hospital, Turkey. Asia Pac J Oncol Nurs. 2014 Apr-Jun;1(1):40-45.

45.Deger C, Telli F, Gunaldi M, Keskin S, Saglam S, Ozdemir O, Sar C, Parali E, Erdal E, Sumer F, Ozel O, Asan S. The Life Time Cost-of-Disease (Cod) of Metastatic Colorectal Cancer (Mcrc) in Turkey: an Expert Panel Approach for Estimation of Costs. Value Health. 2015 Nov;18(7):A448.

46.Deger C, Telli F, Gunaldi M, Keskin S, Saglam S, Ozdemir O, Sar C, Parali E, Erdal E, Sumer F, Ozel O, Asan S. The Cost-of-Disease of Metastatic/Inoperable Gastrointestnal Stromal Tumors in Turkey: an Expert Panel Approach for Estimation of Costs. Value Health. 2015 Nov;18(7):A449.

47.Deger C, Telli F, Gunaldi M, Keskin S, Saglam S, Ozdemir O, Sar C, Parali E, Erdal E, Sumer F, Ozel O, Asan S. The Cost-Effectiveness Of Regorafenib In The Treatment Of Metastatic/Inoperable Gastrointestinal Stromal Tumors In Turkey. Value Health. 2015 Nov;18(7):A455

48.Deger C, Telli F, Gunaldi M, Keskin S, Saglam S, Ozdemir O, Sar C, Parali E, Erdal E, Sumer F, Ozel O, Asan S. The Cost-Effectiveness Of Regorafenib In The Treatment Of Patients With Metastatic Colorectal Cancer (Mcrc) Who Have Progressed After Standard Therapies In Turkey. Value Health. 2015 Nov;18(7):A458.

49.Gunaldi M, Erdem D, Goksu S, Gunduz S, Okuturlar Y, Tiken E, Aksoy H, Yildirim M. Platelet Distribution Width as a Predictor of Metastasis in Gastric Cancer Patients. J Gastrointest Cancer. 2016 Nov 8. DOI 10.1007/s12029-016-9886-5

50.Atakan Demir, Nil Molinas Mandel, Semra Paydas, Gökhan Demir, Özlem Er, Nazım Serdal Turhal, Sevil Bavbek, Yeşim Eralp, Pınar Mualla Saip, Emine Nilüfer Güler, Adnan Aydıner, Başak Oyan Uluç, Sadettin Kılıçkap, Necdet Üskent, Nuri Karadurmuş, Mehmet Ali Kaplan, Mustafa Teoman Yanmaz, Hacer Demir, Özkan Alan, Taner Korkmaz, Polat Olgun, Özlem Sönmez Uysal, Kadri Altundağ, Şeyda Gündüz, Meral Günaldı, Murat Sarı, İsmail Beypınar, Gül Başaran Balkan Med J. 2020 Mar; 37(2): 104–107. Published online 2020 Feb 28. (SCI & SSCI & Arts and Humanities)

7.2.Papers presented at international scientific meetings and published in proceedings

1.Meral Gunaldi., Ismail Oguz Kara., Cigdem Usul Afsar., Berna Bozkurt Duman Sorafenib in the treatment of metastatic paraganglioma: A case report. 2012 ASCO Annual Meeting. 1-5 June Chicago/America (Poster)

2.Berna Bozkurt Duman., Meral Gunaldi., Burcak Evren Tasdogan., Cigdem Usul Afsar, Semra Paydas, Yuksel Gumurdulu Nonalcoholic fatty liver disease after adjuvant therapy in nonmetastatic breast cancer.. ASCO Annual Meeting May June ChicagoAmerica (Poster)

3.Meral Gunaldi., Berksoy Sahin., Ufuk Tatlı Osteonecrosis of the Jaw in patients cancer treated with Bisphosphonates.. Mediterranean Multidisciplinary Oncology Forum Congress, 2011

4.Elif Eda Tiken., Meral Günaldı., Yıldız Okuturlar., Savaş Tuna The evalution synchronous bilateral breast cancer patients.. International Breast Cancer Conference 30 September-02 October, 2014, Istanbul (Poster)

5.Yıldız Okuturlar., Meral Günaldı., Elif Eda Tiken., Savaş Tuna, Bugra Oztosun, Yesim Inan, Tarik Ercan, Ozlem Harmankaya, Baki Kumbasar Evaluation of body mass index in breast cancer patients. International Breast Cancer Conference 30 September-02 October, 2014, Istanbul (Poster)

6.Meral Günaldı., Elif Eda Tiken., Yıldız Okuturlar., Savaş Tuna, Selin Kapan Neoadjuvant chemotherapy in breast cancer patients: Single centre experience.. International Breast Cancer Conference 30 September-02 October, 2014, Istanbul (Poster) (Kontrol No: 1168313)

7.Meral Gunaldi., Melek Erkisi., Cigdem Usul Afsar., Vehbi Ercolak, Semra Paydas, Ismail Oguz Kara, Berksoy Sahin, Umran Gulec, Ata Secilmis The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisims in Turkish breast cancer patients receiving tamoxifen treatment.. ASCO Annual Meeting J Clin Oncol 32, 2014 (Poster) (Kontrol No: 1168351)

8.C Usul Afsar., B Sahin., D Gumurdulu., E Kılıc Bagır, R Burgut, M Erkisi, O Kara, M Gunaldi, V Ercolak The evaluatıon of fıbroblast growth factor receptor 1 (fgfr1), fıbroblast growth factor 2 (fgf2), phosphatıdylınosıtol 3 phosphate kınase (ıp3k) expressıon and theır clınıcal, prognostıc sıgnıfıcance ın early and advanced stage of squamous cell carcınoma of the lung.. 39( th) ESMO Congress (ESMO 2014), Madrid, Spain, 26-30 September, (Poster) (Kontrol No: 1168371)

9.Helvacı A., Çorbacıoğlu E., Günaldı M Acute coronary syndrome and its relation with diabetes mellitus and antidiabetic drug. 59th ESCVS International Congress in conjunction with the 6th Congress of Update in Cardiology and Cardiovascular Surgery which will be held in Cesme, Izmir – Turkey (Poster) (Kontrol No: 1168247)

10.Y Okuturlar., A Gedikbasi., N Akalin., M Gunaldi, D Yilmaz, P Karakaya, M Mert, O Harmankaya Effects of iron therapy on paraoxonase and arylesterase activities in patients with iron deficiency anemia,. IFCC Worldlab Istanbul 2014, 22th International Congress of Clinical Chemistry and Laboratory Medicine, 22-26 June 2014, Istanbul, Turkey (Poster) (Kontrol No: 1168388)

11.Usul Afsar Cigdem, M Gunaldi Okuturlar Yıldız,Gedikbaşı Asuman,Kural Alev Paraoxonase and Arylesterase Activities in Patients with Coloractal Cancer. ADVANCES IN PREDICTIVE & PERSONALIZED MEDICINE (Poster) (Kontrol No: 1410317)

12.M Gunaldi,Usul Afsar Cigdem,Okuturlar Yıldız,Gedikbaşı Asuman,Kural Alev Can Heat Shock Protein 70 be a Target Therapy in Breast Cancer?. ADVANCES IN PREDICTIVE & PERSONALIZED MEDICINE (Poster) (Kontrol No: 1410333)

13.Okuturlar Yıldız, M Gunaldi, Gedikbaşı Asuman,Kural Alev,Acarer Didem Breast cancer and paraoxonase activity. ADVANCES IN PREDICTIVE & PERSONALIZED MEDICINE (Poster) (Kontrol No: 1410292)

14.Işıksaçan Nilgün,Koşer Murat, M Gunaldi, Ördekçi Seyhan C- Reactive Protein (CRP) Measurement Using Point of Care (POC) Devices. ADVANCES IN PREDICTIVE & PERSONALIZED MEDICINE (Poster) (Kontrol No: 1410353)

15.Oztosun buğra,okuturlar yıldız, M Gunaldi, soyluk selçukbiricik özlem,mert meral,sayilan samet,orman mehmet,kaptanoğulları özlem An agressive malign insulinoma: A case report. European Congress of Endocrinology (Poster) (Kontrol No: 1477607)

16.Abbasoğlu duygu, M Gunaldi, sivas hülya,yakıcıer mustafa cengiz,hızel halıt candan The factors affecting UGT1A1 enzyme activity of irinotekan drug response in Turkish Population. 7 th santorini conference systems personalized health and therapy (Poster) (Kontrol No: 1477770)

17.M Gunaldi,helvacı ayşen Alteration in serum levels of selenium and glutathione peroxidase in acute myocardial infarction. 59th ESCVS International Congress in conjunction with the 6th Congress of Update in Cardiology and Cardiovascular Surgery which will be held in Cesme, Izmir - Turkey on 15-18 April 2010. (Poster) (Kontrol No: 1489470)

18.Günaldi Meral, Tiken Elif Eda, Okuturlar Yıldız, Tuna Savaş, Kapan Selin (2014).Neoadjuvant chemotherapy in breast cancer patients: Single centre experience. InternationalBreast Cancer Conference 2014.

19.Okuturlar Yıldız, , Eda Tiken Elif, Tuna Savaş, Öztosun Buğra, İnanyeşim, Ercan Tarik, Harmankaya Özlem, Kumbasar Baki (2014). Evaluation of body massindex in breast cancer patients. International Breast Cancer Conference 2014.

20.Günaldi Meral, Gürgenyataği Dilek, Göksu Sema, Gülenay Şeyda, Yildirim Mustafa, Tiken Elif, Okuturlar Yıldız, Kahraman Sibel (2014). A factor that predicts occurence ofmetastasis on stomach cancer patients: PDW. 4th International Gastrointestinal CancerConference.

21.Okuturlar Yıldız, Günaldi Meral, Gedikbaşi Asuman, Kural Alev, Acarer Didem (2015).Breast Cancer and Paraoxonase Activity. Cancer International Symposium on Advances inPredictive & Personalized Medicine.

22.Gunaldi Meral, Goksu Sema, Gunduz Seyda, Okuturlar Yıldız, Tiken Elif, Kahraman Sibel, Isıksacan Nilgün. Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: A multicenter study. 4th European Congress of Immunology Vienna. September 6-9, 2015.

23.Gunaldi M., Okuturlar Y., Kural A., Akarsu C., Karabulut M., Gedikbasi A.. Clinicalimportance of S100A9 and S100A12 in BreastCancer. 4th EuropeanCongress of ImmunologyVienna. September 6-9, 2015.

24.Gunaldi M., Isıksacan N., Okuturlar Y., Kocoglu H., Gunaldi O.. Clinical significance of serum survivin in cancer patients. 4th European Congress of Immunology Vienna. September 6-9, 2015.

7.3. Authored books or chapters in books.

1.Kanser Chemotherapy Handbook, Chapter name:(Classification, usage and toxicity in chemotherapeutic and molecular targeted therapy) (2013)., Yıldırım Yeşim, GÜNALDI MERAL, Karaarslan Sinan, Çukurova Nobel Kitabevi, Editor: Haluk Onat, Turkish (Book Translation), (Control No: 1410130)

2.Nöroşirurjide shunt surgery, Chapter name:(Ommaya reservoir) (2014)., Günaldı Ömür,GÜNALDI MERAL, Selen Publishing, Turkish (Scientific Book), (Kontrol No: 1410135)

7.4. Articles Published in National Refereed Journals

1.Meral Günaldi,BOZKURT DUMAN BERNA,ERÇOLAK VEHBI,USUL AFŞAR ÇİĞDEM,KARA İSMAİL OĞUZ,ŞAHİN BERKSOY (2012). Three Different Skin Toxicities Associated with Sorafenib: A Case Report;. Turk J Dermatol (Kontrol No: 1168412)

2.YILMAZ GÜLAY,ADAŞ MİNE,HELVACI AYŞEN,ALTINTAŞ NEJAT, Meral Günaldi (2013). Evaluation of Respiratory Functions in Subclinical and Clinical Hypothyroidism. Journal of Turgut Ozal Medical Center (Kontrol No: 1168432)

3.Elif Eda Tiken, Meral Günaldi, Yıldız Okuturlar, Nurten Sever (2014). Metastasis of invasive lobular breast cancer to the stomach: A case report. Turkish Journal of Oncology , 29(4), 157-161., Doi:10.5505/tjoncol.2014.1178

4.Meral Günaldi,BOZKURT DUMAN BERNA,USUL AFŞAR ÇİĞDEM,GÜNALDI ÖMÜR,ŞAHİN BERKSOY (2014). Temporal bone localized langerhans cell histiocytosis: A case report. Göztepe Medical Journal (Control No: 1168445)

5.KARACA FERYAL,ERÇOLAK VEHBI,USUL AFŞAR ÇİĞDEM, Meral Günaldi (2015). Diffuse Large B Cell Lymphoma of the Breast. Cukurova Medical Journal (Control No: 1397858)

6.Meral Günaldi,KÖKSAL ERKİŞİ MELEK (2014). Chemotherapy in Glioblastome Multiforme. Clinical Medical Sciences (Control No: 1409850)

7.Ayşe Gözkaman, Yıldız Okuturlar, Özkan Kanat, Meral Günaldi, Sibel Ocak Serin, Özlem Saydaroğlu, Abdulbaki Kumbasar, Türkkan Evrensel (2015). C-Kit (CD117) Expression in Small-Cell Lung Cancer Patients. HasekiTIpBülteni, 53, 67-71., Doi: 10.4274/haseki.2078

8.Yıldız Okuturlar, Meral Günaldi, Elif Eda Tiken, Savaş Tuna, Buğra Öztosun, Yeşim Özdeminan , Tarık Ercan, Ozlem Harmankaya, Abdulbaki Kumbasar (2015). The Effect of Overweight and Obesity on Breast Cancer Subtypes. Journal of Clinical and Analytical Medicine

9.Elif Eda Tiken, Meral Günaldi, Yıldız Okuturlar, Savaş Tuna. Evaluation of patients with synchronous bilateral breast cancer. Istanbul Medical Journal/Istanbul Medical Journal, Doi: IsanbulMed J. Articles in Print: ITD-85547

10.Yıldız Okuturlar, Meral Mert, Özlem Soyluk, Serkan Enki, Samet Sayilan, Murat Gönenç, Meral Günaldı , Abdulbaki Kumbasar, Halil Aliş, Özlem Harmankaya A Rare Cause of Hypoglycemia Seen in Advanced Age: Insulinoma. Bakirkoy Medical Journal

11.Meral Günaldi,BOZKURT DUMAN BERNA,ERÇOLAK VEHBI,USUL AFŞAR ÇİĞDEM,PAYDAŞ SEMRA,KÖKSAL ERKİŞİ MELEK,KARA İSMAİL OĞUZ,ŞAHİN BERKSOY,GÖNLÜŞEN GÜLFİLİZ (2014). Retrospective Evaluation of Osteosarcomas / Retrospective Anaysis of Osteosarcomas. Journal of Clinical and Analytical Medicine (Control No: 1410954)

12.Meral Günaldi (2014). Breast Cancer Risk Factors. Journal of Clinical Medicine Family Medicine (Control No: 1409880)

13.ÖNER ÖZKARA İREM, Meral Günaldi (2014). Gastric Cancer: Prevention, risk factors and prognosis. Journal of Clinical Medicine Family Medicine (Control No: 1409875)

7.5. Papers presented at national scientific meetings and published in the proceedings book

1.Meral Günaldı., Berna Bozkurt Duman., Vehbi Erçolak., Çiğdem Usul Afşar, Semra Paydaş, İsmail Oğuz Kara, Melek Erkişi, Berksoy Şahin Investigation of Epirubicin and Doxorubicin Contribution to Trastuzumab Associated Cardiotoxicity. 4th Medical Oncology Congress March 21-25, 2012 Antalya, (Control No: 1176853)

2.Meral Günaldı., Semra Paydaş., Çiğdem Usul Afşar., Vehbi Erçolak, Berna Bozkurt Duman, Figen Doran Association of Tuberous Sclerosis and Malignant Melanoma. 4th Medical Oncology Congress March 21-25, 2012 Antalya, (Control No: 1176828)

3.GÜNALDI MERAL Primary Appendiceal Adenocarcinoma Diagnosed with Bilateral Ovarian Metastasis. 4th Medical Oncology Congress March 21-25, 2012, Antalya, (Control No: 1176735)

4.GÜNALDI MERAL Richter Syndrome. Meral Günaldı, Melek Erkişi, Çiğdem Usul Afşar, Berna Bozkurt Duman, Vehbi Erçolak, (Control No: 1176723)

5.Berna Bozkurt Duman., Çiğdem Usul Afşar., Meral Günaldı., Melek Erkişi, Oğuz İsmail Kara, Berksoy Şahin, Pınar Kum Adjuvant/Neoadjuvant Chemotherapy Experience in Breast Cancer Patients. 20th National Cancer Congress April 19-23, 2013, Antalya, (Control No: 1176993)

6.Meral Günaldı., İOğuz Kara., Çiğdem UAfşar., Vehbi Erçolak, Berna B Duman Malignant Mesenchymal Tumor Accompanying Acromegaly. 4th Medical Oncology Congress March 21-25, 2012, Antalya, (Control No: 1176898)

7.Vehbi Ercolak., Semra Paydas., Gülşah Şeydaoğlu., Meral Günaldı, Cigdem Usul Afsar, Berna Bozkurt Duman Retrospective Evaluation in Hodgkin Lymphoma Cases. 5th Medical Oncology Congress, (Control No: 1177105)

8.Meral Gunaldi., Yıldız Okuturlar., Elif Eda Tiken Molecular Subgroup Evaluation in Geriatric Breast Cancer Patients. 1st Geriatrics Oncology Congress, Antalya, September 2014, (Control No: 1177134)

9.Meral Günaldı., Melek Erkişi., Çiğdem Usul Afşar., Berna Bozkurt Duman, Vehbi Erçolak Alpha-2 globulin peak in a patient with lung adenocarcinoma. 4th Medical Oncology Congress March 21-25, 2012, Antalya, (Control No: 1176572)

10.Berna Bozkurt Duman., Berksoy Şahin., Melek Erkişi., Semra Paydaş, Oğuz Kara, Çiğdem Usul Afşar, Meral Günaldı, Vehbi Erçolak, Pınar Kum The Effect of Cytoreductive Nephrectomy on Survival in Metastatic Renal Cell Carcinoma. 4th Medical Oncology Congress March 21-25, 2012, Antalya, (Control No: 1176907)

11.Meral Günaldı., Berksoy Şahin., Berna Bozkurt Duman., Vehbi Erçolak, Çiğdem Usul Afşar Is Bevacizumab a Risk Factor for Osteonecrosis of the Jaw?. 4th Medical Oncology Congress March 21-25, 2012, Antalya,,, (Control No: 1176649)

7.6. Other Publications and Activities

Books:

Current Approaches in Gastrointestinal System Cancers - Treatment of Metastatic Well-Differentiated Gastrointestinal and Pancreatic Neuroendocrine Tumors (February 2022).

Shunt Surgery in Neurosurgery, Chapter Title: (Ommaya Reservoir) (2014). Authors: Ömür Günaldı, Meral Günaldı, Publisher: Selen Publishing, Turkish (Scientific Book).

Cancer Chemotherapy Handbook, Chapter Title: (Classification, Use, and Toxicity in Chemotherapeutic and Molecular Targeted Therapy) (2013). Authors: Yeşim Yıldırım, Meral Günaldı, Sinan Karaarslan, Publisher: Çukurova Nobel Kitabevi, Editor: Haluk Onat, Turkish (Book Translation).

Memberships:

Turkish Medical Oncology Association (TTOD) Board Membership, 2020-2022

Interdisciplinary Oncology Association (IDOD)

Turkish Neuro-Oncology Association

European Society of Medical Oncology (ESMO)

Congress and Symposium Committee Memberships:

Turkish Medical Oncology Cancer Congress

Turkish Medical Oncology Cancer Congress

Turkish Medical Oncology Cancer Congress

Turkish Medical Oncology Association Courses, 2020-2022